Raymond James Downgrades Sionna Therapeutics (SION) to Market Perform
Raymond James analyst Chris Raymond downgraded Sionna Therapeutics (NASDAQ: SION) from Outperform to Market Perform.The analyst comments "Downgrading SION shares ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)